End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 CAD | -1.41% | -11.39% | -40.68% |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-40.68% | 119M | C | ||
+31.96% | 272M | - | ||
+33.74% | 261M | - | ||
+49.42% | 194M | C | ||
+44.98% | 131M | - | ||
-28.57% | 121M | - | - | |
+115.91% | 119M | - | - | |
0.00% | 86.82M | - | - | |
+150.00% | 75.33M | - | - | |
+1.20% | 55.24M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- CBSTF Stock
- CBST Stock
- Ratings The Cannabist Company Holdings Inc.